The suggestion is "followed by label extension in the larger adult population".
We don't know how that label extension would be approved, but it is a shorter pathway than another full BLA for adult GVHD, hence potential saving and quicker time to market. But, it does not mean no additional study or trial for adult GVHD.
ASX Hot too!, page-373
-
- There are more pages in this discussion • 299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.3¢ |
Change
-0.003(0.27%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 92.5¢ | 89.5¢ | $2.715M | 3.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 59346 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 46745 | 31 |
View Market Depth
| Last trade - 14.33pm 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |